Cutting-edge approach for Alzheimer's disease detection in the early stages: an overview.
作者信息
Amin Ruhul, Dey Biplab K, Alam Faruk, Emran Talha B
机构信息
Faculty of Pharmaceutical Science, Assam Down Town University, Panikhaiti, Guwahati, Assam, India.
Department of Pharmacy, BGC Trust University Bangladesh, Chittagong.
出版信息
Int J Surg. 2023 Mar 1;109(3):582-583. doi: 10.1097/JS9.0000000000000177.
Abstract
摘要
相似文献
1
Cutting-edge approach for Alzheimer's disease detection in the early stages: an overview.阿尔茨海默病早期检测的前沿方法：综述
Int J Surg. 2023 Mar 1;109(3):582-583. doi: 10.1097/JS9.0000000000000177.
2
Improving early detection of Alzheimer's disease through MRI slice selection and deep learning techniques.通过磁共振成像切片选择和深度学习技术改善阿尔茨海默病的早期检测。
Sci Rep. 2025 Aug 10;15(1):29260. doi: 10.1038/s41598-025-14476-0.
3
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍（MCI）患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
4
Speech changes in old age: Methodological considerations for speech-based discrimination of healthy ageing and Alzheimer's disease.老年言语变化：基于言语的健康衰老与阿尔茨海默病鉴别方法学的考虑。
Int J Lang Commun Disord. 2024 Jan-Feb;59(1):13-37. doi: 10.1111/1460-6984.12888. Epub 2023 May 4.
5
Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).用于检测轻度认知障碍（MCI）患者中阿尔茨海默病及其他痴呆症的简易精神状态检查表（MMSE）。
Cochrane Database Syst Rev. 2015 Mar 5;2015(3):CD010783. doi: 10.1002/14651858.CD010783.pub2.
6
AADvac1, an Active Immunotherapy for Alzheimer's Disease and Non Alzheimer Tauopathies: An Overview of Preclinical and Clinical Development.AADvac1，一种用于治疗阿尔茨海默病和非阿尔茨海默型 Tau 病的主动免疫疗法：临床前和临床开发概述。
J Prev Alzheimers Dis. 2019;6(1):63-69. doi: 10.14283/jpad.2018.45.
7
The future of Alzheimer's disease risk prediction: a systematic review.阿尔茨海默病风险预测的未来：一项系统综述。
Neurol Sci. 2025 Apr 12. doi: 10.1007/s10072-025-08167-x.
8
Diagnosis of Early Alzheimer's Disease: Clinical Practice in 2021.早期阿尔茨海默病的诊断：2021 年的临床实践。
J Prev Alzheimers Dis. 2021;8(3):371-386. doi: 10.14283/jpad.2021.23.
9
Methodologies for assessing morphosyntactic ability in people with Alzheimer's disease.评估阿尔茨海默病患者形态句法能力的方法。
Int J Lang Commun Disord. 2024 Jan-Feb;59(1):38-57. doi: 10.1111/1460-6984.12862. Epub 2023 Feb 25.
10
WITHDRAWN: Support for carers of people with Alzheimer's type dementia.撤回：对阿尔茨海默病型痴呆患者照料者的支持。
Cochrane Database Syst Rev. 2007 Jul 18(3):CD000454. doi: 10.1002/14651858.CD000454.
引用本文的文献
1
"My Biomarkers Are Fine, Thank You": On the Biomarkerization of Modern Medicine.“我的生物标志物没问题，谢谢”：论现代医学的生物标志物化
J Gen Intern Med. 2025 Feb;40(2):453-457. doi: 10.1007/s11606-024-09019-8. Epub 2024 Sep 25.
本文引用的文献
1
Chromone-based monoamine oxidase B inhibitor with potential iron-chelating activity for the treatment of Alzheimer's disease.具有潜在铁螯合活性的基于色酮的单胺氧化酶 B 抑制剂，用于治疗阿尔茨海默病。
J Enzyme Inhib Med Chem. 2023 Dec;38(1):100-117. doi: 10.1080/14756366.2022.2134358.
2
SOBA: Development and testing of a soluble oligomer binding assay for detection of amyloidogenic toxic oligomers.SOBA：用于检测淀粉样毒性寡聚物的可溶性寡聚物结合测定法的开发和测试。
Proc Natl Acad Sci U S A. 2022 Dec 13;119(50):e2213157119. doi: 10.1073/pnas.2213157119. Epub 2022 Dec 9.
3
The role of Tumour Necrosis Factor in neuroinflammation associated with Parkinson's disease and targeted therapies.肿瘤坏死因子在帕金森病相关神经炎症中的作用及靶向治疗。
Neurochem Int. 2022 Sep;158:105376. doi: 10.1016/j.neuint.2022.105376. Epub 2022 Jun 3.
4
Molecular subtyping of Alzheimer's disease using RNA sequencing data reveals novel mechanisms and targets.利用 RNA 测序数据对阿尔茨海默病进行分子亚型分类揭示了新的机制和靶点。
Sci Adv. 2021 Jan 6;7(2). doi: 10.1126/sciadv.abb5398. Print 2021 Jan.
5
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.血液磷酸化 tau 181 作为阿尔茨海默病的生物标志物：使用来自四个前瞻性队列的数据进行的诊断性能和预测模型研究。
Lancet Neurol. 2020 May;19(5):422-433. doi: 10.1016/S1474-4422(20)30071-5.
6
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.血浆磷酸化 tau181 在阿尔茨海默病和额颞叶变性中的诊断价值。
Nat Med. 2020 Mar;26(3):387-397. doi: 10.1038/s41591-020-0762-2. Epub 2020 Mar 2.
7
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.阿尔茨海默病患者血浆 P-tau181：与其他生物标志物的关系、鉴别诊断、神经病理学和向阿尔茨海默病痴呆的纵向进展。
Nat Med. 2020 Mar;26(3):379-386. doi: 10.1038/s41591-020-0755-1. Epub 2020 Mar 2.
8
Amyloid-peptide β 42 Enhances the Oligomerization and Neurotoxicity of apoE4: The C-terminal Residues Leu279, Lys282 and Gln284 Modulate the Structural and Functional Properties of apoE4.β 淀粉样肽 42 增强 apoE4 的寡聚化和神经毒性：C 端残基亮氨酸 279、赖氨酸 282 和谷氨酰胺 284 调节 apoE4 的结构和功能特性。
Neuroscience. 2018 Dec 1;394:144-155. doi: 10.1016/j.neuroscience.2018.10.026. Epub 2018 Oct 24.
Zotero 插件